CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes
05 août 2020 07h00 HE
|
CB2 Insights
Dharma will license the Company’s proprietary technology platform “Sail” to use at the point of care within Dharma dispensaries and its network of support centers in Virginia.Sail will be used to...